Verici Dx PLC has become an Olink Certified Service Provider, enabling it to offer advanced proteomics assay services from its accredited laboratory. This certification allows the company to support biomarker discovery, algorithm development, and clinical trials for both external clients and its own projects. The Olink platform enhances Verici Dx's ability to analyze large protein datasets, complementing its expertise in genomics and bioinformatics. The company has already applied this capability in a pharmaceutical collaboration involving a GLP-1 clinical trial, demonstrating early practical use of the technology.
A critical vulnerability in Ravencoin's consensus protocol was exploited starting August 7, allowing invalid blocks to be accepted from block height 4,487,776. This flaw bypassed normal mining validation, leading to potentially reversible transaction...
EPR Properties offers two convertible preferred share series: Series C and Series E. Series E provides a higher yield of about 9%, trading at a premium but with a balanced risk-reward profile, including downside protection and equity upside potential...
Solana-based DeFi platform Jupiter has launched Lend v2, an upgrade allowing borrowed assets to be used as decentralized exchange (DEX) liquidity, generating trading fees that can offset borrowing costs. The upgrade introduces Smart Collateral and Sm...
Ethereum (ETH) has experienced increased selling pressure on exchanges throughout August, with net outflows and a price dip from $1920 to $1875 on August 10. Institutional demand softened slightly ahead of the U.S. inflation report scheduled for Augu...
ChipMOS TECHNOLOGIES INC. reported a 28.7% increase in revenue for Q2 2026 compared to Q2 2025, reaching NT$7,383.1 million (US$231.8 million). The company expanded its gross margin to 18% and recorded net earnings of NT$1.28 per basic common share, ...
